The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3
Open accessAbstract
The interaction between silver nanoparticles and viruses is attracting great interest due to the potential antiviral activity of these particles, and is the subject of much research effort in the treatment of infectious diseases. In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with herpes simplex virus types 1 and 2 and with human parainfluenza virus type 3. We show that production of silver nanoparticles from different fungi is feasible, and their antiviral activity is dependent on the production system used. Silver nanoparticles are capable of reducing viral infectivity, probably by blocking interaction of the virus with the cell, which might depend on the size and zeta potential of the silver nanoparticles. Smaller-sized nanoparticles were able to inhibit the infectivity of the viruses analyzed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum
Ahmad, A., Mukherjee, P., Senapati, S., Mandal, D., Khan, M. I., Kumar, R., & Sastry, M. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00174-1 · Cited by 1,976
Interaction of silver nanoparticles with HIV-1
Elechiguerra, J. L., Burt, J. L., Morones, J. R., Camacho-Bragado, A., Gao, X., Lara, H. H., & Yacaman, M. J. (2005) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-3-6 · Cited by 1,709
Fayaz, A. M., Balaji, K., Girilal, M., Yadav, R., Kalaichelvan, P. T., & Venketesan, R. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.006 · Cited by 1,417
Alfalfa Sprouts: A Natural Source for the Synthesis of Silver Nanoparticles
Gardea-Torresdey, J. L., Gomez, E., Peralta-Videa, J. R., Parsons, J. G., Troiani, H., & Jose-Yacaman, M. (2003) · Langmuir · doi:10.1021/la020835i · Cited by 1,085
Mode of antiviral action of silver nanoparticles against HIV-1
Lara, H. H., Ayala-Nuñez, N. V., Ixtepan-Turrent, L., & Rodriguez-Padilla, C. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-1 · Cited by 1,061
Silver Nanoparticles as Potential Antiviral Agents
Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., & Galdiero, M. (2011) · Molecules · doi:10.3390/molecules16108894 · Cited by 963
Self-citationGajbhiye, M., Kesharwani, J., Ingle, A., Gade, A., & Rai, M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.06.005 · Cited by 813
Self-citationNair, B., & Pradeep, T. (2002) · Crystal Growth & Design · doi:10.1021/cg0255164 · Cited by 772
Ahmad, A., Senapati, S., Khan, M. I., Kumar, R., Ramani, R., Srinivas, V, & Sastry, M. (2003) · Nanotechnology · doi:10.1088/0957-4484/14/7/323 · Cited by 695
Silver Nanoparticles Inhibit Hepatitis B virus Replication
Lu, L., Sun, R. W.-Y., Chen, R., Hui, C.-K., Ho, C.-M., Luk, J. M., Lau, G. K., & Che, C.-M. (2008) · Antiviral Therapy · doi:10.1177/135965350801300210 · Cited by 603
Cited by
Zhang, X.-F., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091534 · Cited by 3,220
Silver nanoparticles: Synthesis, medical applications and biosafety
Xu, L., Wang, Y.-Y., Huang, J., Chen, C.-Y., Wang, Z.-X., & Xie, H. (2020) · Theranostics · doi:10.7150/thno.45413 · Cited by 1,315
Ferdous, Z., & Nemmar, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072375 · Cited by 1,019
Silver nanoparticles: synthesis, properties, and therapeutic applications
Wei, L., Lu, J., Xu, H., Patel, A., Chen, Z.-S., & Chen, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.014 · Cited by 970
Synthesis of Silver Nanoparticles Mediated by Fungi: A Review
Guilger-Casagrande, M., & Lima, R. D. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00287 · Cited by 712
Metadata
- Authors
- Galdiero, S., Rai, M., Gade, A., Falanga, A., Incoronato, N., Russo, L., Galdiero, M., Gaikwad, S., & Ingle, A.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2013-11
- Volume
- 8
- Pages
- 4303
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W1980111069
- Cited by
- 373
- References
- 36
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. https://app.cochat.ai/papers/10.2147/ijn.s50070
- The paper
- Galdiero, S., Rai, M., Gade, A., Falanga, A., Incoronato, N., Russo, L., Galdiero, M., Gaikwad, S., & Ingle, A. (2013). Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s50070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.